Richemont delivered strong 1Q27 results, with management communication focused on jewelry growth, customer mix, margins, and cash usage

Overview

This report is Morgan Stanley's post-1Q27 earnings management Q&A checklist for Richemont, rather than a full earnings forecast revision. It raises 10 questions around the quality of sales growth, breakdown by customer group and region, performance of the jewelry and watch businesses, gross margin and cost leverage, management changes, capex, dividends, and M&A. The overall tone is moderately positive, as the company posted first-quarter growth clearly ahead of pressure seen in soft luxury and the watch industry, though the report also stresses that Chinese demand, the durability of high-end U.S. consumption, and market share trends in the watch business still need to be validated.

Core views

The core view is that Richemont's growth momentum is mainly driven by Jewellery Maisons and high-end customers, rather than by price alone. Morgan Stanley focuses on the roughly 6% contribution from volume and mix beyond pricing within the group's +20% CER growth in 1Q27, while also probing the runway for continued growth at brands such as Cartier, Van Cleef & Arpels, and Buccellati. The report believes U.S. and South Korean customers were exceptionally strong, while Chinese customers showed a split between weak domestic demand and recovering overseas spending. On profits, FY26 gross margin was dragged by gold, tariffs, and FX, but the contraction was much smaller excluding FX, suggesting FY27 gross margin pressure may be lower than in FY26; on costs, higher sales density may continue to generate operating leverage.

Analysis framework

The report uses a '10 questions for management' format to work backward from the results and test the operating assumptions that need validation: it first breaks group growth into price, volume, and mix; then analyzes regional and consumer structure by customer groups such as China, the U.S., and South Korea; next it assesses brand performance across jewelry, specialist watchmaking, and other divisions; and finally it evaluates earnings quality and capital allocation through gross margin, expense ratio, management changes, net cash, and M&A policy.

Methodology notes

• Valuation methodsDCF

  Discounted cash flow valuation

  Morgan Stanley states that it uses a DCF valuation approach because it better reflects the company's margin potential and cash flow, with key assumptions including an 8.4% WACC and a 2.5% terminal growth rate.

• Financial forecastingMorgan Stanley ModelWare

  Internal financial modeling framework

  Most financial metrics in the report tables are based on the Morgan Stanley ModelWare framework, while some consensus data come from Refinitiv Estimates.

• Rating systemMorgan Stanley Stock Rating

  Relative rating system

  Overweight indicates that, on a risk-adjusted basis over 12-18 months, the stock's expected total return is above the average expected total return of the analyst's industry coverage universe.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Richemont SA (CFR.S)

  Core covered name

  Strengths

  Jewellery Maisons is delivering strong growth, with Cartier and Van Cleef & Arpels benefiting from global brand advantages; the company also has ample net cash, and the DCF valuation highlights margin and cash flow potential.

  Weaknesses

  The specialist watchmaking division has almost continuously lost market share over the past decade, and part of growth is highly dependent on continued spending by high-end customers in markets such as the U.S. and South Korea.

  Comparison

  Compared with soft luxury brands, Western jewelry brands continue to perform better; relative to Swiss watch export data, Specialist Watchmakers performed better in 1Q27.

  Risks

  A meaningful slowdown in China, cooling U.S. consumption, continued deterioration in the watch business, and pressure on gross margin from gold prices and FX.

• Cartier

  Richemont's core jewelry brand

  Strengths

  The report estimates Cartier grew about +13% at CER in FY26 and asks whether 1Q27 was around +22%; the brand may have performed strongly in both jewelry and watches.

  Weaknesses

  A rising mix of iconic product lines may create tension between accessibility and exclusivity.

  Comparison

  Together with Van Cleef & Arpels, it forms the main growth driver of Jewellery Maisons.

  Risks

  The sustainability of high growth, volume and mix contribution beyond price, and the remaining room to increase penetration among some customer groups need to be validated.

• Van Cleef & Arpels

  Richemont's core jewelry brand

  Strengths

  Its growth rate had previously been viewed as clearly faster than Cartier's, and its high-end positioning and iconic product lines support strong demand.

  Weaknesses

  The report asks whether its current growth has converged with Cartier's, implying that relative outgrowth may be narrowing.

  Comparison

  Compared with Cartier, it had grown faster historically, but in 1Q27 it may also have been delivering strong double-digit growth.

  Risks

  Over-penetration of iconic collections could affect exclusivity and desirability.

• Specialist Watchmakers

  Business division

  Strengths

  It achieved +8% CER growth in 1Q27 despite a weak watch industry backdrop, with Vacheron Constantin, Jaeger-LeCoultre, and A. Lange & Söhne specifically cited as standout performers.

  Weaknesses

  It has almost continuously lost market share over the past decade and is now smaller in scale than Cartier Watches.

  Comparison

  Relative to Swiss watch exports, which declined about 3% by value over the first five months, this division performed better.

  Risks

  A persistently weak watch market, inability to regain market share, and uncertainty over the effectiveness of a 'shrink to grow' strategy.

Key data

• 1Q27 group sales growth+20% CERThe report states that Richemont's group sales grew 20% at constant exchange rates in 1Q27.
• Jewellery Maisons 1Q27 growth+24% CERThe jewelry business is the main growth engine, and the report focuses on the brand performance of Cartier, Van Cleef & Arpels, and Buccellati.
• Specialist Watchmakers 1Q27 growth+8% CERGrowth was achieved against a backdrop of Swiss watch exports by value declining about 3% year-to-date through May, and the report asks what drove this outperformance versus the industry.
• Others 1Q27 growth+9% CERThe report believes this division may have outperformed many soft luxury peers and focuses on Alaia, Chloe, Delvaux, and Peter Millar.
• Estimated 1Q27 growth of Chinese customersabout +9%The report estimates Chinese customers improved from about -1% to -2% in 4Q26 to about +9% in 1Q27, and asks further about the split between mainland and overseas spending.
• Estimated 1Q27 growth of U.S. customersabout +30%The report estimates U.S. customers still grew about +30% on a comparison base of roughly +15%.
• Estimated 1Q27 growth of South Korean customers>+50% YoYThe report believes South Korean customers may have been among the fastest-growing customer groups in 1Q27.
• FY26 gross margin change-250 bpsFY26 gross margin was dragged by gold prices, U.S. tariffs, and adverse FX; excluding FX, the contraction was about -40 bps.
• FY27 consensus gross margin assumption64.2%, down 20 bps YoYThe report asks whether this consensus assumption is reasonable.
• FY26 expense growth+1.5%This was below FY26 sales growth of +4.8%, with the expense-to-sales ratio contracting by about -140 bps.
• FY27 consensus cost leverageexpense-to-sales ratio down -180 bpsThe report asks whether improved sales density can support this operating leverage assumption.
• Net cash€9.1bnAs of June 2026, the company's net cash was at the high end of the full-year 10-year range of €2.4bn to €9.1bn.
• Target price and current priceSFr 200.00 / SFr 197.40The target price is SFr 200.00, and the closing price on July 16, 2026 was SFr 197.40.

Impact & implications

For investment implications, the key issue is not simply confirming strong 1Q27 growth, but judging whether that growth is sustainable and of high quality: if Jewellery Maisons continues to outperform soft luxury, high-end U.S. and South Korean customers remain strong, gross margin headwinds ease, and cost leverage materializes, Richemont's EPS and valuation support would strengthen; conversely, if China weakens at the same time the U.S. slows, or if the watch business continues to lose share, the current Overweight thesis would come under pressure.

Risks

• A meaningful slowdown in China while the U.S. is slowing is listed by the report as Richemont's biggest downside risk.
• The watch business could continue to deteriorate, especially as the long-term market share performance of Specialist Watchmakers still needs improvement.
• High-end U.S. consumption and the wealth effect may prove unsustainable, creating uncertainty over how long strong growth can last.
• Gold prices, U.S. tariffs, and foreign exchange volatility may continue to weigh on gross margin.
• Over-penetration of iconic jewelry product lines could weaken brand exclusivity and desirability.
• Morgan Stanley discloses that it has investment banking and other service relationships with Richemont SA, and investors should be aware of potential conflicts of interest.

What to watch

• Whether 2Q27 sales trends continue the strong 1Q27 performance, especially volume and product mix contribution from Jewellery Maisons.
• Whether the divergence between mainland China consumption and overseas consumption by Chinese consumers narrows or widens.
• Whether the high growth of U.S. and South Korean customer groups is sustained in July and beyond.
• The growth rates, whitespace, and product line structure of Cartier, Van Cleef & Arpels, and Buccellati.
• Whether Specialist Watchmakers can regain market share with support from Vacheron Constantin, Jaeger-LeCoultre, and A. Lange & Söhne.
• Whether FY27 gross margin contracts only slightly, and whether pressure from FX, gold, and tariffs eases.
• Whether the expense-to-sales ratio declines by about -180 bps as consensus expects, validating operating leverage.
• How the €9.1bn net cash is used, including ordinary dividends, special dividends, capex, and potential M&A.